JAAD OnlineStrategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic
Cited by (0)
Funding sources: None.
Disclosure: Dr Shi is a stock shareholder of Learn Health and has served as an advisory board member and/or investigator and/or has received research funding from Sanofi Genzyme, Regeneron, AbbVie, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Menlo Therapeutics, Burt’s Bees, GpSkin, Altus Labs, and Skin Actives Scientific; there were no incentives or transactions, financial or otherwise, relevant to this manuscript. Dr Curiel-Lewandrowski has served as an advisory board member and/or investigator and/or has received research funding from Amgen, Bristol-Myers Squibb, Helsinn, and Novartis; there were no incentives or transactions, financial or otherwise, relevant to this manuscript. Ms Price and Dr Thiede have no conflicts of interest to declare.
IRB approval status: Not applicable.
Reprints not available from the authors.